Skip to main content

Table 5 Relation between demographic and clinical characteristics of patients with mono-viral infection and viral co-infection

From: Co-infections of human herpesviruses (CMV, HHV-6, HHV-7 and EBV) in non-transplant acute leukemia patients undergoing chemotherapy

Variables

Active viral infection

(N = 84)

No. (%)

Active mono-viral infection

(N = 61)

No. (%)

Active viral co-infection

(N = 23)

No. (%)

P

Sex

 Male

54 (64.3)

34 (55.7)

20 (86.9)

0.007

 Female

30 (35.7)

27 (44.3)

3 (13)

 

Age (years)

  < 16

49(58.3)

37 (60.7)

12 (52.2)

0.482

  ≥ 16

35 (41.7)

24 (39.3)

11 (47.8)

 

Type of leukemia

 AML

36 (42.9)

25 (41)

11 (47.8)

0.572

 ALL

48 (57.1)

36 (59)

12 (52.2)

 

Status of disease

 Newly diagnosed

9 (10.7)

7 (11.5)

2 (8.7)

0.443

 Remission

54 (64.3)

41 (67.2)

13 (56.5)

 

 Refractory or relapse

21 (25)

13 (21.3)

8 (34.8)

 

Chemotherapy received

 Before chemotherapy

9 (10.7)

7 (11.5)

2 (8.7)

0.607

 Post-induction

21 (25)

13 (21.3)

8 (34.8)

 

 Post-remission

28 (33.3)

22 (36)

6 (26.1)

 

 Post-salvage

26 (31)

19 (31.1)

7 (30.4)

 

Clinical outcome

 Alive

72 (85.7)

55 (90.2)

17 (74)

0.058

 Dead

12 (14.3)

6 (9.8)

6 (26)

 

Fever

56 (66.6)

41 (67.2)

15 (65.2)

0.863

Severe neutropenia

48 (57.2)

32 (52.5)

16 (69.5)

0.158

Prolonged neutropenia

38 (45.3)

27 (44.3)

11 (47.8)

0.209

Severe lymphopenia

45 (53.5)

25 (41)

20 (87)

< 0.001

Anemia

28 (33.3)

20 (32.8)

8 (43.8)

1.000

Thrombocytopenia

29 (34.5)

21 (34.4)

8 (43.8))

0.986

Skin rash

17 (20.2)

8 (13.1)

9 (39.1)

0.04

Mucositis

5 (6)

3 (5)

2 (8.7)

0.514

Pneumonia

17 (20)

8 (13.1)

9 (39)

0.008

Gastroenteritis

10 (11.9)

7 (11.5)

3 (13)

0.843

Hepatitis

12 (14.3)

7 (11.5)

5 (21.7)

0.231

Conjunctivitis

2 (2.4)

0 (0)

2 (8.7)

–

CNS disorders

7 (8.3)

3 (5)

4 (17.4)

0.065

Other infection

BSI

16 (19)

6 (9.8)

10 (43.5)

< 0.001

IFI

14 (16.6)

7 (11.5)

7 (30.4)

0.038

  1. Viral infections were divided into two groups based on the number of viruses detected: active mono-viral infections and co-infections
  2. Severe neutropenia [ANC < 500/μL]; Prolonged neutropenia [if it persisted over 7 days]; Severe lymphopenia [ALC < 500/μL]; Anemia [hemoglobin < 11 g/L], Thrombocytopenia [platelet count < 100 10 3/ μL]; CNS disorders Central Nervous System disorders, BSI Blood Stream Infection, IFI Invasive Fungal Infection
  3. Statistically significant p are bolded